Latest Investor Communications News

BlackRock Investment Management (Australia) Limited has announced confirmed cash distributions for four Australian iShares ETFs, detailing payment schedules and reinvestment options for investors.

BlackRock Investment Management (Australia) Limited has announced the distribution schedule for its Australian iShares ETFs, with key dates spanning early to mid-February 2026. Investors are reminded to update details and consider the Distribution Reinvestment Plan ahead of the record date.

AMCIL Limited reported a 14.8% increase in half-year profit to $4.1 million, maintaining its interim dividend amid a portfolio return that lagged the ASX 200 benchmark.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for several Australian-domiciled iShares ETFs for the December 2025 distribution period, providing key details for investors opting into reinvestment.

BlackRock Investment Management (Australia) Limited has announced the final cash distributions for over 30 Australian domiciled iShares ETFs listed on the ASX and CBOE Australia, detailing payment schedules and reinvestment options.

Betashares Capital Ltd has announced the Distribution Reinvestment Plan (DRP) issue prices for over 60 of its ETFs following the December 2025 distribution period, offering investors a clear path to reinvest dividends.

Betashares Capital Ltd has announced the final distribution amounts for over 60 of its ETFs for the December 2025 period, alongside details on the Distribution Reinvestment Plan and key payment dates.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for 16 Australian-listed iShares ETFs, with payments scheduled for early January 2026. The announcement outlines distribution amounts, key dates, and important investor compliance reminders.

Resources & Energy Group Limited (REZ) has requested an immediate voluntary suspension of its securities on the ASX as it prepares to announce a capital raising. The suspension is expected to lift by the start of trading on 16 December 2025 or upon the announcement release.

Radiopharm Theranostics reports promising interim Phase 2b results for RAD 101, achieving 92% concordance with MRI in detecting brain metastases, paving the way for a pivotal study in 2026.

RMA Global Limited has firmly denied allegations of selective disclosure following a December 4 webinar that coincided with a notable share price rise. The company insists no new price sensitive information was shared beyond prior ASX announcements.

Charter Hall Group is set to execute a capital reallocation of 42.28 cents per security, shifting capital from its limited company shares to property trust units without cash exchanges. This move, approved by securityholders, carries important tax implications for investors.